{"id":22042,"date":"2025-04-30T07:09:28","date_gmt":"2025-04-30T05:09:28","guid":{"rendered":"https:\/\/xd3kj9bvqee.preview.infomaniak.website\/?p=22042"},"modified":"2025-04-30T07:09:29","modified_gmt":"2025-04-30T05:09:29","slug":"marie-andree-gamache-managing-director-pierre-fabre-medical-care","status":"publish","type":"post","link":"https:\/\/www.industries-cosmetiques.fr\/en\/marie-andree-gamache-managing-director-pierre-fabre-medical-care\/","title":{"rendered":"Marie-Andr\u00e9e Gamache, General Manager, Pierre Fabre Medical Care"},"content":{"rendered":"

Marie-Andr\u00e9e Gamache has been appointed General Manager of Pierre Fabre Laboratories' Medical Care Division. In this capacity, she joins the Pierre Fabre Laboratories Management Committee and reports to Eric Ducournau, Group CEO.<\/p>\n\n\n\n

Canadian-born Marie-Andr\u00e9e Gamache has been working in the pharmaceutical industry for over 25 years. She has held a variety of management positions at national, regional and global level, in Europe, North America, Asia, the Middle East and Africa. She has extensive experience in management and P&L positions, with expertise ranging from pipeline to commercialization.<\/p>

Advertising<\/div>
\"site-industries-cosmetiques<\/a><\/div><\/div>\n\n\n\n

Prior to joining Pierre Fabre Laboratories, Marie-Andr\u00e9e was CEO of Novartis for the UK and Ireland. Prior to that, she joined Novartis in 2019 as Head of Oncology for the Middle East and Africa, after spending four years at Merck KGAA as General Manager in Belgium and Sub-Saharan Africa.<\/p>\n\n\n\n

In 2024, Pierre Fabre Laboratories' Medical Care business achieved sales of 1.3 billion euros, divided between oncology (39 %), dermatology (15 %), chronic diseases (26 %) and family health (13 %). Marie-Andr\u00e9e's main priorities will be to maintain the momentum of the oncology portfolio, via new indications and territories, to optimize sales and profitability of the rest of the Medical Care portfolio, and to prepare for the next decade by overseeing the development of the R&D pipeline in precision oncology, medical dermatology and rare diseases.<\/p>\n\n\n\n

\"We are delighted to welcome Marie-Andr\u00e9e, whose international experience and expertise, particularly in oncology, will undoubtedly drive our Medical Care business forward. Throughout her career, Marie-Andr\u00e9e has demonstrated an exceptional commitment to patient-centeredness, medical innovation, execution excellence and team cohesion. We look forward to realizing new projects together.<\/em>said Eric Ducournau, CEO of Pierre Fabre Laboratories.<\/p>\n\n\n\n

\"I'm delighted to be joining Pierre Fabre Laboratories and its Medical Care teams, who have achieved so much over the past 5 years. I love creating the right environment to accelerate medical innovation and improve access to medicines for patients around the world. The raison d'\u00eatre of Pierre Fabre Laboratories, which is to take care of everyone in order to make the world a better place, resonates deeply with my values. I look forward to taking Pierre Fabre Medical Care to the next level,<\/em> said Marie-Andr\u00e9e Gamache.<\/p>","protected":false},"excerpt":{"rendered":"

Marie-Andr\u00e9e Gamache a \u00e9t\u00e9 nomm\u00e9e au poste de directrice g\u00e9n\u00e9rale de la division Medical Care des Laboratoires Pierre Fabre. \u00c0 ce titre, elle rejoint le comit\u00e9 de direction des Laboratoires Pierre Fabre et rapporte \u00e0 Eric Ducournau, directeur g\u00e9n\u00e9ral du groupe. D\u2019origine canadienne, Marie-Andr\u00e9e Gamache travaille depuis plus de 25 ans dans l’industrie pharmaceutique. Elle […]<\/p>\n","protected":false},"author":148,"featured_media":22044,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"external_url":"","footnotes":""},"categories":[56],"tags":[61],"class_list":{"0":"post-22042","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-management","8":"tag-info-marche"},"acf":{"nc":"Laure.Sgandurra@pierre-fabre.com","nc2":"","nc3":"","nc4":"","nc5":"","nom_url":"Site internet","lien_url":"https:\/\/www.pierre-fabre.com\/"},"_links":{"self":[{"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/posts\/22042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/users\/148"}],"replies":[{"embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/comments?post=22042"}],"version-history":[{"count":0,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/posts\/22042\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/media\/22044"}],"wp:attachment":[{"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/media?parent=22042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/categories?post=22042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/tags?post=22042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}